Innovating products with cutting-edge research
Pear Therapeutics conducts ongoing clinical trials to develop and evaluate innovative products across many indications.
Pear Therapeutics is currently registering participants with chronic insomnia for our DREAM study using an investigational digital therapeutic.
If you have a smartphone and would like to see if you are eligible for the study, please complete this short form and we will email an invitation to begin screening. Invitations are typically sent within 10 days of completing the form. Please look for an email from Pear Therapeutics.
The DREAM study is registered with the National Institutes of Health on clinicaltrials.gov and can be be viewed here.
Eligible participants will have access to an investigational digital therapeutic for 9 weeks and will be eligible for compensation for completing post-assessments.